Activation of the PERK-eIF2 pathway is associated with tumor-infiltrating lymphocytes in HER2-positive breast cancer
- Authors
- Kim, J.Y.; Heo, S.-H.; Song, I.H.; Park, I.A.; Kim, Y.-A.; Gong, G.; Lee, H.J.
- Issue Date
- Jun-2016
- Publisher
- International Institute of Anticancer Research
- Keywords
- Breast cancer; HER2; P-eIF2; PERK; PS6; Tumor-infiltrating lymphocytes
- Citation
- Anticancer Research, v.36, no.6, pp 2705 - 2711
- Pages
- 7
- Journal Title
- Anticancer Research
- Volume
- 36
- Number
- 6
- Start Page
- 2705
- End Page
- 2711
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71133
- ISSN
- 0250-7005
1791-7530
- Abstract
- Background: We evaluated endoplasmic reticulum stress and unfolded protein response (UPR) activation, as possible mechanisms for influx of tumor infiltrating lymphocytes (TILs), and the correlation between UPR activation and mammalian target of rapamycin (mTOR) pathway activation. Materials and Methods: TILs and the immunohistochemical expression of protein kinase RNA-like endoplasmic reticulum kinase (PERK), phospho-eukaryotic translation initiation factor 2 (p-eIF2) and phosphorylated S6 (pS6) were evaluated in 447 human epidermal growth factor receptor 2 (HER2)-positive breast cancer tissues. Results: High expression of PERK, peIF2 and pS6 was observed in 270 (60.4%), 259 (57.9%), and 187 (41.8%) cases, respectively, and was significantly associated with a high histological grade, high numbers of TILs, peritumoral lymphocytic infiltration, and tertiary lymphoid structures in HER2-positive breast cancer tissues. Conclusion: The results suggest endoplasmic reticulum stress and UPR activation as possible mechanisms for the influx of TILs in HER2-positive breast cancer. Evaluation of PERK and p-eIF2 expression might be important in identifying targets for cancer therapies in modulating endoplasmic reticulum stress.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.